Contact lens polymer matrix

A contact lens polymer matrix is a synthetic biomaterial, typically composed of hydrogels like poly(2-hydroxyethyl methacrylate) (pHEMA) or silicone hydrogels, designed to sit on the cornea for vision correction or therapeutic delivery (Source: PubMed, PMID: 31415850). While not a biological target in the traditional pharmacological sense, it serves as a critical interface for drug delivery in ophthalmic therapy by acting as a reservoir for pharmaceutical agents (Source: Journal of Controlled Release, 2020). The matrix is engineered to provide optical clarity, mechanical stability, and high oxygen permeability to maintain corneal health while facilitating the controlled release of drugs into the precorneal tear film (Source: Wikipedia, Contact Lens). This approach aims to improve patient compliance and drug bioavailability compared to traditional eye drops, which often suffer from rapid nasolacrimal drainage. However, challenges include maintaining the material's physical properties while loaded with drugs and preventing adverse reactions like protein deposition or microbial keratitis (Source: StatPearls, Contact Lens Complications). Ultimately, the polymer matrix represents a sophisticated drug-device combination rather than a molecular receptor.

Other names

Hydrogel matrixSilicone hydrogel matrixpHEMA matrixOphthalmic polymer scaffoldDrug-eluting contact lens matrix

The matrix acts as a reservoir that releases therapeutic agents via passive diffusion, ion-exchange, or molecular imprinting into the precorneal tear film (Source: Journal of Controlled Release, 2020).